MCKESSON DL-,01/ US58155Q1031 /
5/31/2024 9:50:42 PM | Chg. +5.400 | Volume | Bid9:59:58 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
523.800EUR | +1.04% | 10 Turnover: 5,207.400 |
523.800Bid Size: 30 | 525.000Ask Size: 30 | 68.26 bill.EUR | - | - |
GlobeNewswire
5/29
Newsweek and Plant-A Insights Group Announce Second Annual America’s Greatest Workplaces for LGBTQ+ ...
GlobeNewswire
5/15
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Globe Life Inc. (GL) Securities ...
GlobeNewswire
5/10
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Globe Life Inc. (GL) Securities ...
GlobeNewswire
5/10
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
5/8
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Globe Life Inc. (GL) Securities ...
GlobeNewswire
5/7
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
4/15
Shah Capital nominates two highly qualified independent director candidates for Novavax
GlobeNewswire
4/10
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
4/1
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class...
GlobeNewswire
3/27
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities ...
GlobeNewswire
3/25
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class...
GlobeNewswire
3/20
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class...
GlobeNewswire
3/19
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Son...
GlobeNewswire
3/18
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities ...
GlobeNewswire
2/6
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular ...